Article
Biopharmaceutical Classification System (BCS)
2025-06-09
Abstract excerpt
A BCS-based biowaiver for generic drugs requires high drug solubility throughout the physiological pH range plus identical product quality and near-identical reference product content to meet recommendation standards outlined by the 2017 FDA Guidance. The International Council for Harmonization gave its authorization to these procedures during 2018. The FDA employs identical terms while discussing BCS-based biowai...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2ac1ad23-a25e-5be9-8c75-0f40a8d46e2f
- DOI
- 10.20944/preprints202506.0622.v1
